| Tiffany Nicole Bell, MD | |
|
101 Dudley St, Providence, RI 02905-2401 | |
| (401) 430-1440 | |
| Not Available |
| Full Name | Tiffany Nicole Bell |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 101 Dudley St, Providence, Rhode Island |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386204261 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | LP04675 (Rhode Island) | Primary |
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043378656 PECOS PAC ID: 3779495858 Enrollment ID: O20080519000558 |
News Archive
Adding the drug dasatinib to a standard antihormone therapy, letrozole, doubled the time before disease progressed for women with hormone receptor-positive, HER2-negative metastatic breast cancer, according to results of a phase II clinical trial presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.
News outlets report on a variety of health issues at the state level including stricter rules for drug abusers in the health industry in California, an examination of the nation's first city-run universal health care plan in San Francisco, a cigarette tax in Florida, sex offenders and ex-convicts in nursing homes in Illinois and efforts to battle medical errors in New Jersey.
The U.S. Food and Drug Administration today approved a new indication for Tasigna (nilotinib) for the treatment of a rare blood cancer when it is first diagnosed. The cancer, called Philadelphia chromosome positive chronic phase chronic myeloid leukemia (Ph+ CP-CML), is a slowly progressing blood and bone marrow disease linked to a genetic abnormality.
When it comes to cancer, there are obvious mind-body links. Stress, pessimism and other emotional factors have been proven to play a role, increasing the risk of cancer, metastasis and early mortality. This is a double-whammy for cancer patients, who must overcome anxiety from the moment they are diagnosed. In particular, stress has been shown to depress the immune system, increase inflammation and affect our bodies on the molecular level, even damaging DNA.
› Verified 9 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1942546486 PECOS PAC ID: 3779495858 Enrollment ID: O20141111002041 |
News Archive
Adding the drug dasatinib to a standard antihormone therapy, letrozole, doubled the time before disease progressed for women with hormone receptor-positive, HER2-negative metastatic breast cancer, according to results of a phase II clinical trial presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.
News outlets report on a variety of health issues at the state level including stricter rules for drug abusers in the health industry in California, an examination of the nation's first city-run universal health care plan in San Francisco, a cigarette tax in Florida, sex offenders and ex-convicts in nursing homes in Illinois and efforts to battle medical errors in New Jersey.
The U.S. Food and Drug Administration today approved a new indication for Tasigna (nilotinib) for the treatment of a rare blood cancer when it is first diagnosed. The cancer, called Philadelphia chromosome positive chronic phase chronic myeloid leukemia (Ph+ CP-CML), is a slowly progressing blood and bone marrow disease linked to a genetic abnormality.
When it comes to cancer, there are obvious mind-body links. Stress, pessimism and other emotional factors have been proven to play a role, increasing the risk of cancer, metastasis and early mortality. This is a double-whammy for cancer patients, who must overcome anxiety from the moment they are diagnosed. In particular, stress has been shown to depress the immune system, increase inflammation and affect our bodies on the molecular level, even damaging DNA.
› Verified 9 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1457023616 PECOS PAC ID: 3779495858 Enrollment ID: O20220105001262 |
News Archive
Adding the drug dasatinib to a standard antihormone therapy, letrozole, doubled the time before disease progressed for women with hormone receptor-positive, HER2-negative metastatic breast cancer, according to results of a phase II clinical trial presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.
News outlets report on a variety of health issues at the state level including stricter rules for drug abusers in the health industry in California, an examination of the nation's first city-run universal health care plan in San Francisco, a cigarette tax in Florida, sex offenders and ex-convicts in nursing homes in Illinois and efforts to battle medical errors in New Jersey.
The U.S. Food and Drug Administration today approved a new indication for Tasigna (nilotinib) for the treatment of a rare blood cancer when it is first diagnosed. The cancer, called Philadelphia chromosome positive chronic phase chronic myeloid leukemia (Ph+ CP-CML), is a slowly progressing blood and bone marrow disease linked to a genetic abnormality.
When it comes to cancer, there are obvious mind-body links. Stress, pessimism and other emotional factors have been proven to play a role, increasing the risk of cancer, metastasis and early mortality. This is a double-whammy for cancer patients, who must overcome anxiety from the moment they are diagnosed. In particular, stress has been shown to depress the immune system, increase inflammation and affect our bodies on the molecular level, even damaging DNA.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tiffany Nicole Bell, MD 903 Providence Pl Apt 264, Providence, RI 02903-7008 Ph: () - | Tiffany Nicole Bell, MD 101 Dudley St, Providence, RI 02905-2401 Ph: (401) 430-1440 |
News Archive
Adding the drug dasatinib to a standard antihormone therapy, letrozole, doubled the time before disease progressed for women with hormone receptor-positive, HER2-negative metastatic breast cancer, according to results of a phase II clinical trial presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.
News outlets report on a variety of health issues at the state level including stricter rules for drug abusers in the health industry in California, an examination of the nation's first city-run universal health care plan in San Francisco, a cigarette tax in Florida, sex offenders and ex-convicts in nursing homes in Illinois and efforts to battle medical errors in New Jersey.
The U.S. Food and Drug Administration today approved a new indication for Tasigna (nilotinib) for the treatment of a rare blood cancer when it is first diagnosed. The cancer, called Philadelphia chromosome positive chronic phase chronic myeloid leukemia (Ph+ CP-CML), is a slowly progressing blood and bone marrow disease linked to a genetic abnormality.
When it comes to cancer, there are obvious mind-body links. Stress, pessimism and other emotional factors have been proven to play a role, increasing the risk of cancer, metastasis and early mortality. This is a double-whammy for cancer patients, who must overcome anxiety from the moment they are diagnosed. In particular, stress has been shown to depress the immune system, increase inflammation and affect our bodies on the molecular level, even damaging DNA.
› Verified 9 days ago
Donald Ramos, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 695 Eddy St, Providence, RI 02903 Phone: 401-272-1550 Fax: 401-421-8792 | |
Brittany S Hampton, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 101 Dudley St, Providence, RI 02905 Phone: 401-274-1100 | |
Dr. Jane R. Sharp, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 297 Promenade St, Providence, RI 02908 Phone: 401-490-6464 | |
Dr. Katharine D Wenstrom, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 101 Dudley Street, 3rd Floor, Women & Infants Hospital Of Rhode Island/mfm Division, Providence, RI 02905 Phone: 401-274-1122 Fax: 401-453-7622 | |
Rebecca Crichton, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 101 Dudley St, Providence, RI 02905 Phone: 401-274-1122 | |
Heather A Smith, MD, MPH Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 101 Dudley St, Providence, RI 02905 Phone: 401-274-1122 | |
Meena Theva, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 101 Dudley St, Providence, RI 02905 Phone: 401-274-1122 |